Ups and Downs for Melanoma. But Staying Focused.

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 25 June 2015 In Science

 This time a week ago I was jubilant. The SU2C-MRA Melanoma Dream Team’s paper describing a precision medicine approach to treating patients had just been published. And in the middle of the week an important article published in the prestigious scientific journal Cell describing the comprehensive genomic landscape of over...

Read More

On the Path to Precision Medicine for Melanoma Patients

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 16 June 2015 In Science

There is no denying the transformative success of new treatments for melanoma ranging from molecularly targeted agents for BRAF-mutant melanoma to immunotherapies like anti-CTLA4 and anti-PD-1 drugs. Indeed, the treatment of BRAF-mutant melanoma is a prime example of Precision Medicine; that is, matching treatments to a patient’s specific disease.

Read More

Why #ItsTHATWorthIt to Me to Protect My Skin

By Lauren Leiman | 10 June 2015 In Allies & Partnerships, Events, Prevention

This summer, L'Oréal Paris, in partnership with the Melanoma Research Alliance (MRA), is asking women everywhere to demonstrate why it’s imperative to protect their skin, beauty, and life through the #ItsTHATWorthIt social media campaign. To help kick off the campaign, L'Oréal hosted two events – one in Los Angeles and...

Read More

The Latest in Melanoma Research: News from the Two Biggest Cancer Meetings

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 4 June 2015 In News, Science

There’s been a lot of news on melanoma treatments in the last couple of weeks coming out of the two largest cancer conferences held each year: the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) annual meetings.

Read More

Let’s Continue the Momentum

By Logan Kastner, MRA Director of Marketing and Development | 3 June 2015 In Allies & Partnerships, Prevention

The month of May flew by with a tremendous amount of energy and effort devoted to raising awareness and funds for melanoma. It was inspiring to see so much buzz in the news and on social media about the importance of using sun protection and taking the appropriate steps to...

Read More

Leveraged Finance Fights Melanoma Raises $1.6 Million for Melanoma Research

By Jennifer Engel, MRA Development Manager, Foundations and Campaigns | 29 May 2015 In Allies & Partnerships, Events, Treatment

On May 19, the Melanoma Research Alliance (MRA) took over Rockefeller Center for its Fourth Annual Leveraged Finance Fights Melanoma (LFFM) cocktail event.  As a customary kick-off to summer, industry executives gathered to raise funds for melanoma research and learn about the importance of early detection and sun safety.

Read More

Melanoma Awareness: The Importance of Early Detection

15 May 2015 In Prevention

When caught early, melanoma is highly curable.

Read More

Corporate Partners Join in the Fight Against Melanoma

By Logan Kastner, MRA Director of Marketing and Development | 8 May 2015 In Allies & Partnerships

Melanoma Awareness Month is off to a great start! We have so many people and corporations to thank for all they are doing to raise awareness of this deadly cancer. Like so many of you, the Melanoma Research Alliance is committed to ending death and suffering caused by melanoma.

Read More

Breakthrough Medicine: Highlights from Milken Institute's Global Conference

1 May 2015 In Events, Science

Chief Science Officer Louise Perkins moderated a panel at the 2015 Milken Institute Global Conference, titled \"Breakthrough Medicine: Will Finding a Cure Be Just the Start of Saving Lives?\"

Read More

A Patient's Take on MRA's Scientific Retreat

25 March 2015 In Events, Science

Melanoma patient and blogger T.J. Sharpe attended the Melanoma Research Alliance's Scientific Retreat last month. While the retreat is primarily intended as a way for doctors and researchers to share the latest information on melanoma research, we try to include patients, foundations, families and others who care about melanoma.

Read More